Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
PanGenomic Health, Inc. Class A (TSE:NARA)
:NARA
NARA Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.07 - C$1.30
Previous CloseN/A
Volume0.00
Average Volume (3M)21.67K
Market Cap
C$1.41M
Enterprise ValueC$386.73K
Total Cash (Recent Filing)88.53K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.30
Next Earnings
May 06, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.73
Shares Outstanding6,399,814
10 Day Avg. Volume47,193
30 Day Avg. Volume21,671
Standard Deviation0.25
R-Squared0.10
Alpha-0.10
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)22.90
P/FCF Ratio22.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
PanGenomic Health, Inc. Class A News
PremiumCompany Announcements
PanGenomic Health Reprices Warrants to Enhance Market Appeal
PremiumCompany Announcements
PanGenomic Health Secures $750,000 via Private Placement Offering
PremiumCompany Announcements
PanGenomic Health Proposes Repricing of Warrants
PremiumCompany Announcements
PanGenomic Health’s $750K Private Placement Announcement
PremiumCompany Announcements
PanGenomic Health Unveils Latest Financial Figures
PremiumCompany Announcements
PanGenomic Health Set to Resolve Filing Delays
PremiumCompany Announcements
PanGenomic Health Nears Filing Overdue ReportsPremiumCompany Announcements
PanGenomic Health Nears Financial Filing Completion---
Options Prices
Currently, No data available
---
Ownership Overview
46.14%
Insiders
― Other Institutional Investors
53.86% Public Companies and
Individual Investors
NARA FAQ
What was PanGenomic Health, Inc. Class A’s price range in the past 12 months?
PanGenomic Health, Inc. Class A lowest stock price was C$0.07 and its highest was C$1.30 in the past 12 months.
What is PanGenomic Health, Inc. Class A’s market cap?
PanGenomic Health, Inc. Class A’s market cap is C$1.41M.
When is PanGenomic Health, Inc. Class A’s upcoming earnings report date?
PanGenomic Health, Inc. Class A’s upcoming earnings report date is May 06, 2025 which is in 92 days.
How were PanGenomic Health, Inc. Class A’s earnings last quarter?
PanGenomic Health, Inc. Class A released its earnings results on Nov 28, 2024. The company reported -C$0.154 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.154.
Is PanGenomic Health, Inc. Class A overvalued?
According to Wall Street analysts PanGenomic Health, Inc. Class A’s price is currently Overvalued.
Does PanGenomic Health, Inc. Class A pay dividends?
PanGenomic Health, Inc. Class A does not currently pay dividends.
What is PanGenomic Health, Inc. Class A’s EPS estimate?
PanGenomic Health, Inc. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PanGenomic Health, Inc. Class A have?
PanGenomic Health, Inc. Class A has 6,399,814 shares outstanding.
What happened to PanGenomic Health, Inc. Class A’s price movement after its last earnings report?
PanGenomic Health, Inc. Class A reported an EPS of -C$0.154 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 50%.
Which hedge fund is a major shareholder of PanGenomic Health, Inc. Class A?
Currently, no hedge funds are holding shares in TSE:NARA
---
Company Description
PanGenomic Health, Inc. Class A
PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's unique user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The company's digital therapeutics clinic platform, the PlantGx Platform, provides health practitioners with access to a consumer's Nara App data in order to assist them to optimize the identification of appropriate natural remedies and monitor a patient's prognosis during treatment.
---
Technical Analysis
---